Chronic Kidney Disease Drug Development

  • Event Date
    1 Mar, 2022 - 3 Mar, 2022
  • Event Time
    9:00 am - 6:00 pm
  • Category
  • Event Price

As SGLT2 inhibitors redefine standard of care, opportunities to establish efficacy with surrogate endpoints take a step forward, and molecular phenotyping of disease etiology enables reclassification of patients to clinically actionable subtypes; drug development for chronic kidney disease has never been more exciting.

Event Contact
Address: Boston, USA
Phone: TBC
1. Auto & Automotive 2. Building & Construction 3. Agriculture & Forestry 4. Medical & Pharma 5. Industrial Engineering 6. Science & Research 7. Business Services 8. Education & Training
Business conferences and year-round community contact are Hanson Wade's specialty. We accelerate growth in every industry and around the world, and we're here to help. Finding the proper people, issues, and solutions allows us to achieve commercial outcomes quickly and with minimal risk to our customers. Our staff is based in London and works all over the world. North America, Europe, Africa, the Middle East, and South America all host big events.
Sign in to your account